Turning Point Therapeutics, Inc.
Chiral diaryl macrocycles as modulators of protein kinases

Abstract:

The present disclosure relates to certain chiral diaryl macrocyclic derivatives, of the formula I: ##STR00001## pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.